Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
> Pharma China Web Edition
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
News
2/19/2024
India Mulls New PLI Scheme to Reduce Chinese API Dependency
2/19/2024
IMD: China Is Becoming Tech, Pharma Powerhouse
2/19/2024
Gilead and Biocytogen Strike a Multi-Target Antibody Collaboration Dea...
2/19/2024
CDE Solicits Comments on Draft Implementation Suggestions and Chinese ...
2/16/2024
China CDC Becomes First WHO Collaboration Centre on Injury Prevention ...
2/16/2024
Ethical Concerns Prompt Largest Mass Retraction of Chinese Genetics Pa...
2/16/2024
FDA Criticizes Chinese API Producer for Deceptive Practices and Qualit...
2/15/2024
LianBio Completes Strategic Review for Winding Down of Its Operations
2/10/2024
Recent Executive Moves
2/10/2024
Drug R&D and Product Registration News Digest February 2024 (1)
2/8/2024
China Drug Sales Performance of Top Seven MNC Pharma Cos in 2023
2/8/2024
China Issues the Action Plan for National Emergency Clinical Trials fo...
2/7/2024
CDE Issues the Technical Guidelines for Pharmaceutical Research on Mic...
2/7/2024
CDE Issues the Dossier References for Drug R&D and Technical Evaluatio...
2/7/2024
CDE Issues the Technical Guidelines for Pharmaceutical Research and Ev...
2/7/2024
CDE Issues the List of Reference Formulations for GQCE Studies (77th B...
2/7/2024
NMPA Restores Import, Sales and Use of GSK's BPH Drug
2/7/2024
Review and Outlook of China's Foreign Trade of Medicines and Health Pr...
2/7/2024
Review of Chinese Anti-tumor Hospital Drug Sales in 2023: Pharnexcloud
2/7/2024
China's Basic Medical Insurance System Reports Revenue of CNY 2.7T in ...
2/7/2024
Boao Lecheng Pilot Zone Experiments Expedited Entry into China's Healt...
2/7/2024
NHC: China Continues to Improve Access to Public Medical Services
(Free)
2/7/2024
I-Mab to Divest China Operations and Become a US-Focused Biotech
2/7/2024
China Proposes Accelerated Approval for Local Production of Biologics
2/7/2024
NMPA Issues the Pilot Reform Work Plan for Optimizing Drug Supplementa...
2/7/2024
NHSA Solicits Comments for Draft Incentive Document on Initial Pricing...
2/6/2024
China Nearly Doubles Class 1 New Drugs in 2023
2/6/2024
Luye Pharma Collaborates with Myung In Pharm in Advancing Treatment f...
2/6/2024
Potential Impact of the US Bill on Wuxi AppTec and Its Western Drugmak...
2/6/2024
CPC Expels Former Healthare Reform Official
Page:
38
/
41
Total number of articles:
1204
:
[First]
[<<]
[36]
[37]
[38]
[39]
[40]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit